Plus   Neg

Sangamo Biosciences Inc. (SGMO) Is Up Sharply On Q4 Results & Collaboration

Sangamo Biosciences Inc. (SGMO) announced Thursday morning that it has entered into a worldwide collaboration with Kite, a Gilead Company (GILD).

The company also reported a fourth quarter loss of $0.15 per share, compared to the loss of $0.14 per share last year. Analysts expected a loss of $0.18.

Sangamo Biosciences has gapped open sharply higher Thursday morning and is now up 4.35 at $26.55 on above average volume. The stock has surged to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT